Concomitant glucose-dependent insulinotropic receptor (GIPR) and glucagon-like peptide-1 receptor (GLP1R) agonism stimulates TG-rich lipoprotein metabolism and attenuates atherosclerosis development. (August 2021) - Modder, M.; Van Eenige, R.; Ying, Z.; Qu, H.; Coskun, T.; Kooijman, S.; Rensen, P.C.N.